Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
GeminiBio Strengthens Board of Directors with Addition of Bryan Poltilove
Gemini BioProducts (GeminiBio), a portfolio company of BelHealth, a Florida-based healthcare private equity firm, and […]
Celyad Oncology Appoints Georges Rawadi as Its New CEO
Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]
Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer
Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets […]
Morphimmune Appoints Dr. Clay Siegall Chief Executive Officer and President
Morphimmune, a preclinical biotechnology company focused on developing targeted oncology therapeutics, today announced the appointment […]
Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel
Capstan Therapeutics, a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted […]
Ankyra Therapeutics Appoints Experienced Financial Executive Stephen Gorgol as Chief Financial Officer
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, has […]
Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO
Semler Scientific, a company that provides technology solutions to improve the clinical effectiveness and efficiency […]
Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors
NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that […]
Gamida Cell Announces Changes to Board of Directors
Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, today announced […]
Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer
Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more